Dharushana Muthulingam is an Infectious Disease physician affiliated with Washington University in St. Louis. OpenAlex indexes 17 publications with 392 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1004 Kennerly Rd
Ste 171 B
Saint Louis, MO 63128
Telephone
314-821-0900Provider last certified this registry record 19 Jul 2021.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20251 payment
- ViiV Healthcare CompanyProgram year20251 payment
- ViiV Healthcare CompanyProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
33.7%Opioid Agonist33.7%Hydrocodone-Acetaminophen100%Part D≥11 patientsNervous system
29.3%SSRI15.2%Escitalopram Oxalate100%Part D<11 patientsOpioid Agonist14.1%Oxycodone-Acetaminophen100%Part D<11 patientsCardiovascular
25%Thiazide diuretic13%Hydrochlorothiazide100%Part D<11 patientsStatin12%Atorvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2020 per NIH RePORTER. The latest:
- Developing and Pilot Testing a Decision Aid for Opioid Use Disorder Treatment with Incarcerated Individuals Anticipating Release
Washington University
FY2020$98,680K23DA049689
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis
Journal of Substance Use and Addiction Treatment
2023 - Sex, Love, Survival: a Tale of Two Plagues (Opening Talk)
OSF Preprints (OSF Preprints)
2021 - Evaluation of Partial Oral Antibiotic Treatment for Persons Who Inject Drugs and Are Hospitalized With Invasive Infections
Clinical Infectious Diseases
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Ley, MD
Washington University in St. Louis
David Gutmann, MD
Washington University in St. Louis
Randall Bateman, MD
Washington University in St. Louis
Victoria Fraser, MD
Washington University in St. Louis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”